MDC now officially the same valuation as MXC and looking like it will be less value soon. Pretty much the last 2.5 years of research and clinical trials has resulted in a significant decrease in value to the company. One would ask what was the point? Interesting fact MXC has a 140% increase since IPO and now MDC has a 30% decrease since IPO. One could make the conclusion that MXC is the better company to date... thoughts?
Add to My Watchlist
What is My Watchlist?